International League of Dermatological Societies
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled Analysis
Publication
15 Nov 2024
Currently there are no policies in place that require researchers to consider the sex and gender of the people who participate in research trials in the UK. This means that studies are not required to report results about sex or gender differences, and very often do not report these findings. Therefore, both the public and healthcare providers are denied potentially crucial findings about women, men, trans and non-binary people which could influence the medical care they receive.
The MESSAGE (Medical Science Sex and Gender Equity) project team of collaborators from TGI UK, Imperial College London, and Queen Mary University of London, will work together with members of the public, other researchers, and funding and drug regulatory bodies, to develop best practice recommendations and a sex and gender policy framework to improve gendered health outcomes in the UK. This policy framework will be supported by educational and training materials to guide the implementation of the project’s recommendations.